ConductScience.org, home

Paper ยท 31398337

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.

Riquelme E and 30 others. Cell, 2019. Cited by 1,293 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Papers, record 31398337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31398337

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
PubMed
Journal
Cell
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,293
iCite
Relative citation ratio, by iCite
47.9
iCite
Revised in PubMed
2020-08-08
PubMed

Authors31

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Riquelme EErick
2Zhang YYu
3Zhang LLiangliang
4Montiel MMaria
5Zoltan MMichelle
6Dong WWenli
7Quesada PPompeyo
8Sahin IIsmet
9Chandra VVidhi
10San Lucas AAnthony

1 to 10 of 31Source PubMed

See all 31 authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Pancreatic DuctalMajor topic
Gastrointestinal MicrobiomeMajor topic
Pancreatic NeoplasmsMajor topic
Adult
Aged
Animals
Bacteria
Cell Line, Tumor
Cohort Studies
Fecal Microbiota Transplantation
Feces
Female
Humans
Male
Mice
Mice, Inbred C57BL
Middle Aged
RNA, Ribosomal, 16S
Sequence Analysis, RNA
Survival Rate

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 CA218690NCI NIH HHSUnited StatesK08CA218690PubMedNIH RePORTER
K12 CA088084NCI NIH HHSUnited StatesK12CA088084PubMedNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMedNIH RePORTER
R25 CA056452NCI NIH HHSUnited StatesR25CA056452PubMedNIH RePORTER

Trials4

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04787991Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic AdenocarcinomaBackgroundClinicalTrials.gov
NCT07818421Intratumoral Microbiota and Immune Microenvironment in Prostate CancerResultsClinicalTrials.gov
NCT07845565FMT Plus SHR-1701 With Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaBackgroundClinicalTrials.gov
NCT07854977Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.BackgroundClinicalTrials.gov

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in31,471,581Tumour microbiome defines outcomes.https://conductscience.org/library/papers/31471581PubMed
Comment in31,477,872Tumour microbiome defines outcomes.https://conductscience.org/library/papers/31477872PubMed
Comment in31,530,941Microbes as biomarkers and targets in pancreatic cancer.https://conductscience.org/library/papers/31530941PubMed

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,567,829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.Cancer Discov2018https://conductscience.org/library/papers/29567829PubMed
229,214,046High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia.NPJ Biofilms Microbiomes2017https://conductscience.org/library/papers/29214046PubMed
329,051,489Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers.Nat Commun2017https://conductscience.org/library/papers/29051489PubMed
429,132,146Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.Nature2017https://conductscience.org/library/papers/29132146PubMed
523,842,501Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.Nature2013https://conductscience.org/library/papers/23842501PubMed
620,709,691Search and clustering orders of magnitude faster than BLAST.Bioinformatics2010https://conductscience.org/library/papers/20709691PubMed
720,979,621Differential expression analysis for sequence count data.Genome Biol2010https://conductscience.org/library/papers/20979621PubMed
821,700,674UCHIME improves sensitivity and speed of chimera detection.Bioinformatics2011https://conductscience.org/library/papers/21700674PubMed
922,699,609Structure, function and diversity of the healthy human microbiome.Nature2012https://conductscience.org/library/papers/22699609PubMed
1027,253,694Cancer treatment and survivorship statistics, 2016.CA Cancer J Clin2016https://conductscience.org/library/papers/27253694PubMed

Cited by999

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,293 citations.

PMIDTitleJournalYearIn PapersSource
42,979,040Naringenin in pancreatic cancer: emerging evidence on the tumor immune-stromal microenvironment, immunometabolic reprogramming, microbiota-host crosstalk, and therapeutic resistance.Front Immunol2026https://conductscience.org/library/papers/42979040PubMed
42,967,594The microbiome and brain metastasis in non-small cell lung cancer: A graded appraisal and a framework for prevention-oriented research.Clin Transl Med2026https://conductscience.org/library/papers/42967594PubMed
42,957,707Genome mining of the tumor microbiome reveals biosynthetic diversity and potential pathology-modulating metabolites.Nat Commun2026https://conductscience.org/library/papers/42957707PubMed
42,957,626Autophagy and intratumoral bacteria abundance influence the prognosis of patients with pancreatic carcinoma.Cell Death Dis2026https://conductscience.org/library/papers/42957626PubMed
42,950,024A systematic pan-cancer analysis of intratumoral microbiota-derived epitopes to inform cancer immunotherapy and prevention.Sci Adv2026https://conductscience.org/library/papers/42950024PubMed
42,941,196Gut Microbiome Compositional and Functional Signatures Associated with Chemotherapy Response in Pancreatic Ductal Adenocarcinoma: An Exploratory Cohort Study.Metabolites2026https://conductscience.org/library/papers/42941196PubMed
42,935,951Microbial-derived metabolites in cancer: evidence boundaries, immune mechanisms and translational pathways.Front Immunol2026https://conductscience.org/library/papers/42935951PubMed
42,930,196Canadian National Pancreas Conference 2025: Recent Advances in Patient-Centred Management of Pancreatic Cancer.Curr Oncol2026https://conductscience.org/library/papers/42930196PubMed
42,909,229Gut mycobiome dysbiosis in digestive system cancers: immune remodeling and translational implications.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42909229PubMed
42,903,607The intratumoral microbiome in breast cancer: an actionable component of the tumor immune microenvironment.Front Immunol2026https://conductscience.org/library/papers/42903607PubMed

1 to 10 of 999

See all 999 cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CEACAM81,088PubTator's text mininghttps://conductscience.org/library/genes/1088NCBI Gene
CTLA41,493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
FOXP350,943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
GZMB3,002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
KIT3,815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
PDX13,651PubTator's text mininghttps://conductscience.org/library/genes/3651NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31398337

GET https://conductscience.org/api/papers/v1/31398337/authors?page=2